Guan; Huiping Amy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guan; Huiping Amy.The latest application filed is for "pyrrolotriazine compounds and methods of inhibiting tam kinases".

Company Profile

7.9.11

Guan; Huiping Amy - Acton MA
Guan; Huiping Amy - Collegeville PA
Guan; Huiping Amy - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrrolotriazine compounds and methods of inhibiting TAM kinases Grant 11,040,981 - Moebius , et al. June 22, 2	2021-06-22
Pyrrolotriazine Compounds And Methods Of Inhibiting Tam Kinases App 20210147431 - Moebius; David ; et al.	2021-05-20
Pyrrolotriazine Compounds And Methods Of Inhibiting Tam Kinases App 20200317676 - Moebius; David ; et al.	2020-10-08
Tam Kinase Inhibitors App 20200291018 - ZHANG; Yi ; et al.	2020-09-17
Compounds as rearranged during transfection (RET) inhibitors Grant 10,709,695 - Demartino , et al.	2020-07-14
Tam Kinase Inhibitors App 20200071326 - Zhang; Yi ; et al.	2020-03-05
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20190247382 - Demartino; Michael P. ; et al.	2019-08-15
Compounds as rearranged during transfection (RET) inhibitors Grant 10,292,975 - Demartino , et al.	2019-05-21
Compounds as rearranged during transfection (RET) inhibitors Grant 10,294,236 - Cheung , et al.	2019-05-21
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20190022078 - DEMARTINO; Michael P. ; et al.	2019-01-24
Compounds as rearranged during transfection (RET) inhibitors Grant 10,111,866 - Demartino , et al. October 30, 2	2018-10-30
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20180147194 - DEMARTINO; Michael P. ; et al.	2018-05-31
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20180099976 - Cheung; Mui ; et al.	2018-04-12
Pyridone derivatives as rearranged during transfection (RET) kinase inhibitors Grant 9,918,974 - Demartino , et al. March 20, 2	2018-03-20
Compounds as rearranged during transfection (RET) inhibitors Grant 9,879,021 - Cheung , et al. January 30, 2	2018-01-30
Pyridone Derivatives As Rearranged During Transfection (ret) Kinase Inhibitors App 20170340617 - DEMARTINO; Michael P. ; et al.	2017-11-30
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20170298074 - CHEUNG; Mui ; et al.	2017-10-19
Compounds as rearranged during transfection (RET) inhibitors Grant 9,035,063 - Eidam , et al. May 19, 2	2015-05-19
Compounds As Rearranged During Transfection (ret) Inhibitors App 20150099762 - EIDAM; Hilary Schenck ; et al.	2015-04-09
Compounds as rearranged during transfection (RET) inhibitors Grant 8,937,071 - Eidam , et al. January 20, 2	2015-01-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.